ID

41047

Descrição

Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01085617

Link

https://clinicaltrials.gov/show/NCT01085617

Palavras-chave

Versões (1)
  1. 16/06/2020 16/06/2020 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

16 de junho de 2020

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Leukemia NCT01085617

Inglês

Eligibility Leukemia NCT01085617

1 Formulários  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01085617
Criteria
Descrição

Criteria

newly diagnosed, previously untreated acute lymphoblastic leukemia
Descrição

Acute lymphocytic leukemia Untreated

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0023449
UMLS CUI [1,2]
C0332155
a pre-phase steroid treatment of 5-7 days is required and can be started prior to registration
Descrição

Steroid therapy Early treatment phase Required

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0814494
UMLS CUI [1,3]
C1514873
philadelphia chromosome-negative or -positive patients are eligible
Descrição

Patients Philadelphia chromosome negative Eligible | Patients Philadelphia chromosome positive Eligible

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C3888511
UMLS CUI [1,3]
C1548635
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0856536
UMLS CUI [2,3]
C1548635
no blast transformation of chronic myeloid leukemia
Descrição

Blast Phase Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0005699
UMLS CUI [1,2]
C0332197
no mature b-cell leukemia [i.e., burkitt disease t(8,14)(q24 ;q32)] or variant c-myc translocations [e.g., t(2;8)(p12;q24), t(8;22)(q24;q11)]
Descrição

Mature B-cell type acute leukaemia Absent | Burkitt Lymphoma Absent | C-Myc Translocation Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0854800
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006413
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1511357
UMLS CUI [3,2]
C0332197
patients who undergo study transplantation must have hla-compatible sibling or unrelated donor
Descrição

Transplantation HLA Match Sibling | Transplantation Unrelated Donor

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0040732
UMLS CUI [1,2]
C4330149
UMLS CUI [1,3]
C0037047
UMLS CUI [2,1]
C0040732
UMLS CUI [2,2]
C3179133
8/8 molecular match at -a, -b, -c, and -dr (dq mismatch is permitted)
Descrição

HLA Match HLA-A Antigens | HLA Match HLA-B Antigens | HLA Match HLA-C Antigens | HLA Match HLA-DR Antigens | HLA Mismatch HLA-DQ Antigens allowed

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4330149
UMLS CUI [1,2]
C0019728
UMLS CUI [2,1]
C4330149
UMLS CUI [2,2]
C0019737
UMLS CUI [3,1]
C4330149
UMLS CUI [3,2]
C0019751
UMLS CUI [4,1]
C4330149
UMLS CUI [4,2]
C0019764
UMLS CUI [5,1]
C4287887
UMLS CUI [5,2]
C0019761
UMLS CUI [5,3]
C0683607
patients meeting ≥ 1 the following criteria are considered high-risk:
Descrição

Criteria Quantity Fulfill | Patients High risk

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1550543
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C4319571
over 40 years old
Descrição

Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
wbc ≥ 30 x 10^9/l (precursor-b) or ≥ 100 x 10^9/l (t-lineage)
Descrição

White Blood Cell Count procedure | Pre-B Lymphocytes | T-Lymphocyte Lineage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0312738
UMLS CUI [3,1]
C0039194
UMLS CUI [3,2]
C0282637
any 1 or more of the following cytogenetic abnormalities:
Descrição

Cytogenetic abnormalities Quantity

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0008625
UMLS CUI [1,2]
C1265611
t(4;11)(q21;q23)/mll-af4
Descrição

t(4;11)(q21;q23) | MLL/AF4

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1515769
UMLS CUI [2]
C1706478
low hypodiploidy/near triploidy (30-39 chromosomes/60-78 chromosomes)
Descrição

Hypoploidy low | Near Triploidy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0333691
UMLS CUI [1,2]
C0205251
UMLS CUI [2,1]
C1706276
UMLS CUI [2,2]
C3536727
complex karyotype (≥ 5 chromosomal abnormalities)
Descrição

Complex Karyotype

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3273253
philadelphia chromosome t(9;22) (q34;q11)/bcr-abl1 (detected by cytogenetic or molecular methods)
Descrição

Philadelphia Chromosome

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0031526
high-risk minimal-residual disease after completion of part 2 standard induction therapy
Descrição

High risk of Residual Neoplasm

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0242596
patient characteristics:
Descrição

Client Characteristics

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0815172
no known hiv infection
Descrição

HIV Infection Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0019693
UMLS CUI [1,2]
C0332197
not pregnant or nursing (no nursing during and for 12 months after completion of study therapy)
Descrição

Pregnancy Absent | Breast Feeding Absent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Descrição

Pregnancy test negative

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception during and for up to 12 months after completion of study therapy
Descrição

Females & males of reproductive potential Contraceptive methods

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C4034483
UMLS CUI [1,2]
C0700589
prior concurrent therapy:
Descrição

Prior Therapy Concurrent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0205420
see disease characteristics
Descrição

ID.23

Tipo de dados

boolean

Voltar ao início da página

Similar models

Eligibility Leukemia NCT01085617

1 Formulários
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT01085617
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Acute lymphocytic leukemia Untreated
Item
newly diagnosed, previously untreated acute lymphoblastic leukemia
boolean
C0023449 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Steroid therapy Early treatment phase Required
Item
a pre-phase steroid treatment of 5-7 days is required and can be started prior to registration
boolean
C0149783 (UMLS CUI [1,1])
C0814494 (UMLS CUI [1,2])
C1514873 (UMLS CUI [1,3])
Patients Philadelphia chromosome negative Eligible | Patients Philadelphia chromosome positive Eligible
Item
philadelphia chromosome-negative or -positive patients are eligible
boolean
C0030705 (UMLS CUI [1,1])
C3888511 (UMLS CUI [1,2])
C1548635 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C0856536 (UMLS CUI [2,2])
C1548635 (UMLS CUI [2,3])
Blast Phase Absent
Item
no blast transformation of chronic myeloid leukemia
boolean
C0005699 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Mature B-cell type acute leukaemia Absent | Burkitt Lymphoma Absent | C-Myc Translocation Absent
Item
no mature b-cell leukemia [i.e., burkitt disease t(8,14)(q24 ;q32)] or variant c-myc translocations [e.g., t(2;8)(p12;q24), t(8;22)(q24;q11)]
boolean
C0854800 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006413 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1511357 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Transplantation HLA Match Sibling | Transplantation Unrelated Donor
Item
patients who undergo study transplantation must have hla-compatible sibling or unrelated donor
boolean
C0040732 (UMLS CUI [1,1])
C4330149 (UMLS CUI [1,2])
C0037047 (UMLS CUI [1,3])
C0040732 (UMLS CUI [2,1])
C3179133 (UMLS CUI [2,2])
HLA Match HLA-A Antigens | HLA Match HLA-B Antigens | HLA Match HLA-C Antigens | HLA Match HLA-DR Antigens | HLA Mismatch HLA-DQ Antigens allowed
Item
8/8 molecular match at -a, -b, -c, and -dr (dq mismatch is permitted)
boolean
C4330149 (UMLS CUI [1,1])
C0019728 (UMLS CUI [1,2])
C4330149 (UMLS CUI [2,1])
C0019737 (UMLS CUI [2,2])
C4330149 (UMLS CUI [3,1])
C0019751 (UMLS CUI [3,2])
C4330149 (UMLS CUI [4,1])
C0019764 (UMLS CUI [4,2])
C4287887 (UMLS CUI [5,1])
C0019761 (UMLS CUI [5,2])
C0683607 (UMLS CUI [5,3])
Criteria Quantity Fulfill | Patients High risk
Item
patients meeting ≥ 1 the following criteria are considered high-risk:
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C4319571 (UMLS CUI [2,2])
Age
Item
over 40 years old
boolean
C0001779 (UMLS CUI [1])
White Blood Cell Count procedure | Pre-B Lymphocytes | T-Lymphocyte Lineage
Item
wbc ≥ 30 x 10^9/l (precursor-b) or ≥ 100 x 10^9/l (t-lineage)
boolean
C0023508 (UMLS CUI [1])
C0312738 (UMLS CUI [2])
C0039194 (UMLS CUI [3,1])
C0282637 (UMLS CUI [3,2])
Cytogenetic abnormalities Quantity
Item
any 1 or more of the following cytogenetic abnormalities:
boolean
C0008625 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
t(4;11)(q21;q23) | MLL/AF4
Item
t(4;11)(q21;q23)/mll-af4
boolean
C1515769 (UMLS CUI [1])
C1706478 (UMLS CUI [2])
Hypoploidy low | Near Triploidy
Item
low hypodiploidy/near triploidy (30-39 chromosomes/60-78 chromosomes)
boolean
C0333691 (UMLS CUI [1,1])
C0205251 (UMLS CUI [1,2])
C1706276 (UMLS CUI [2,1])
C3536727 (UMLS CUI [2,2])
Complex Karyotype
Item
complex karyotype (≥ 5 chromosomal abnormalities)
boolean
C3273253 (UMLS CUI [1])
Philadelphia Chromosome
Item
philadelphia chromosome t(9;22) (q34;q11)/bcr-abl1 (detected by cytogenetic or molecular methods)
boolean
C0031526 (UMLS CUI [1])
High risk of Residual Neoplasm
Item
high-risk minimal-residual disease after completion of part 2 standard induction therapy
boolean
C0332167 (UMLS CUI [1,1])
C0242596 (UMLS CUI [1,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
HIV Infection Absent
Item
no known hiv infection
boolean
C0019693 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing (no nursing during and for 12 months after completion of study therapy)
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Females & males of reproductive potential Contraceptive methods
Item
fertile patients must use effective contraception during and for up to 12 months after completion of study therapy
boolean
C4034483 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Prior Therapy Concurrent
Item
prior concurrent therapy:
boolean
C1514463 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
ID.23
Item
see disease characteristics
boolean
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial